Summer Training Report

On

“MARKETING STRATEGIES FOR NEW

PRODUCT PROMOTION”

FOR

NEW DELHI

Submitted By:

GAURAV KUMAR PANDEY

PGDBA (2008-2010)
IIIrd Semester
Marketing &H.R

GRADUATE SCHOOL OF BUSINESS &

ADMINISTRATION
Sector Alpha-02, Greater Noida – 201306, NCR, INDIA
Ph: 0120 – 2320521, 23, 24, 25 ; Fax : 0120 – 2320522
E. mail: netgsba @nda.vsnl.net.in; Website: www.gsbaindia.org

G.S.B.A, Greater Noida Page 1

 ACKNOWLEDGEMENT

I would like to express my deep sense of gratitude to Miss Mona Singh (ASM, Dr.
Reddy’s Lab.Div. Ventura, New Delhi) who offered me this opportunity to do Summer Training
in such a prestigious company.

I would also like to express my heartfelt thanks to Dr. P.L. Maggu (Executive Director,
G.S.B.A. Greater Noida) and T.N. Srivastava (Head of Training & Placement Department) for
their continued and inspiring guidance.

Appreciation also goes to Mr. Ram Kishore (Professional Service Representative) who
directly or indirectly helped me for the completion of this project.

Finally, I express my deep regards to Prof. Arpita Srivastava (HOD, Marketing

Department, GSBA) ,as well as for our mentor Prof. Sandeep Agarwal & all the other
respondents of Dr. Reddy’s Lab. who had given their valuable responses for the completion of
this project.

G.S.B.A, Greater Noida Page 2

 PREFACE

This is the project report on “MARKETING STRATEGIES ON NEW PRODUCT

PROMOTION”.

The topic of the study was decided by DR. REDDY’S LAB. LTD., DELHI. The
study was conducted in the market with the help of Chemists and Doctors through
questionnaire.

The study was confined to potential market of Delhi City. All efforts were made to
conduct this study, as study was intended to help management in decision making. All the
information & finding are presented in a simplified manner.

GAURAV KUMAR PANDEY

ROLL NO- D-08-12

G.S.B.A, Greater Noida Page 3

 OBJECTIVE

This project is completed by watching Doctors prescriptions and Interacting with chemists. Data collected
through this helped me to know the availability and potential of DR.REDDY’S product in the market.

During interaction with the chemists, I got an opportunity to observe that how the new product is
promoted And old products are retained and what strategies need to be adopted so that product can show
excellent performance in the market.

Since I was focused on Pediatrics Dept., so I took the following factors which may be helpful in
increasing the sales of DRL, these are:-

 Frequent Doctors Visits.

 Availability of products with retailers.
 Cost of product.
 Relations with Doctors.
 Samples & Gifts.
 Advertisement in medical journals.

G.S.B.A, Greater Noida Page 4

 CONTENT

 PROJECT

 ACKNOWEDGEMENT

 PREFACE

 OBJECTIVE OF THE PROJECT.

 SNAP SHOTS OF DRL

 Z&D AGAINST DIARRHOEA

 ANALYSIS OF SUMMER TRAINING.

 QUESSTIONNAIRES.

 BIBLIOGRAPHY.

G.S.B.A, Greater Noida Page 5

DR.REDDY’S LAB. LTD

G.S.B.A, Greater Noida Page 6

Dr. Reddy’s Laboratories Ltd. (DRL) Established in 1984, Dr. Reddy’s Laboratories is an emerging
global pharmaceutical company.

As a fully integrated pharmaceutical company, our purpose is to provide affordable and innovative
medicines through our three core businesses:

• Pharmaceutical Services and Active Ingredients, comprising our Active Pharmaceuticals and
Custom Pharmaceuticals businesses;
• Global Generics, which includes branded and unbranded generics; and
• Proprietary Products, which includes New Chemical Entities (NCEs), Differentiated Formulations,
and Generic Biopharmaceuticals.

Dr. Reddy's aim is to help people lead healthier lives through two parallel objectives:-

(1). Delivering affordable and accessible medication to all parts of the world;

(2). Discovering, developing and commercializing innovative medicines that satisfy unmet medical needs.

HEAD OFFICE --

Dr.Reddy’s Laboratories.Ltd.
7- 1 - 27 Ameerpet,

G.S.B.A, Greater Noida Page 7

 Hyderabad 500 016.INDIA
Tel: +91-40-23731946
Fax: +91-40-23731955
Email: webmaster@drreddys.com

"Everyone has a purpose in life and a unique talent to give to others. And
when we blend this unique talent with service to others, we experience the
- Dr. Anji Reddy ecstasy and exultation of own spirit, which is the ultimate goal of all goals."

WHAT DRL SAYS ABOUT ITS PRODUCTS………?

We, at Dr. Reddy's, bank on the strength of our products. Not only are they the logical results of our
efforts, they are also our means of achieving our end purpose of ‘helping people lead healthier lives’.
Products are the only aspect of our pharmaceutical value chain, which directly touch people’s lives.

Our discovery centric philosophy, along with our internationally ratified facilities, enables us manufacture
a range of products that are known for their quality and efficacy.

G.S.B.A, Greater Noida Page 8

PRODUCTS OF DR. REDDY’S LAB. Ltd-

Active Pharmaceutical Ingredients (API): Dr. Reddy's Laboratories product list span 24 major
chemistries including stereo-selective synthesis, cryogenics, hydrogenations and cyanations. It has filed
84 US DMFs, the highest in India and second highest in the world.
Custom Pharmaceutical Services: Dr. Reddy's executes cost-effective and time-bound projects for its
customers, and provides them cGMP-compliant products manufactured in FDA-inspected, ISO-certified
facilities.

Generic Dosages: Dr. Reddy's Lab is a leading generic drugs manufacturer. It is the fourth largest player
in Germany after the acquisition of betapharm. The company has expertise in customer-specific
packaging, compliance packaging, anti-counterfeit packaging, and has won several awards globally for its
packaging efforts, including the Asia Star, AmeriStar and WordStar awards.

Branded Dosages: Dr. Reddy's brands such as Omez (Omeprazole), Nise (Nimesulide), Stamlo
(Amlodipine), Ciprolet (Ciprofloxacin), Enam (Enalapril) and Ketorol (Ketorolac) are leaders in their
category in several countries.

Discovery Research: Dr. Reddy's is actively involved in drug-discovery and clinical development
programs.

KEY PRODUCTS-
Top-15 active pharmaceutical ingredients
• Ciprofloxacin Hydrochloride
• Ramipril
• Terbinafine HCI

G.S.B.A, Greater Noida Page 9

 • Ibuprofen
• Sertaline Hydrochloride
• Ranitidine HCI Form 2
• Naproxen Sodium
• Naproxen
• Atorvastatin
• Montelukast
• Losartan Potassium
• Sparfloxacin
• Nizatidine
• Ranitidine Hydrochloride Form 1
• Clopidogrel

Top-10 brands in India

• Omez
• Nise
• Stalmo
• Stalmo Beta
• Enam
• Atocor
• Razo
• Reclimet
• Clamp
• Mintop

• An integrated development across economic, environmental

and social parameters is our firm commitment to
stakeholders

G.S.B.A, Greater Noida Page 10

 •

At Dr Reddy's, we strive for:

Economically, generating surpluses that can be re-invested for the
sustainable benefit of all our stakeholders - shareholders, employees,
government, suppliers, customers and lenders.
Socially, creating a positive impact through business and voluntary
initiatives for the benefit of the local and international community.
Environmentally, adopting a proactive approach towards protecting our
fragile world through clean and green practices and initiatives.

G.S.B.A, Greater Noida Page 11

MARKETING IN PHARMACEUTICAL INDUSTRY-

Marketing in Pharmaceutical industry is totally different from other industries like FMCG.
Industrial goods etc. because of following reasons :-

• The pharmaceutical product does not reach directly as the patients consume only
those brands which are being prescribed by the doctor so as we know companies
can’t sell directly to patients i.e the end users of the products is away from
companies. So there can’t be concept of direct seeking in the pharma market. So it is
doctor who is the customer for companies.
• Pharma marketing is also different as the product is technical in nature as compared
to any consumer product. The product has to undergo various clinical trails, medical
test, before it is introduced in the market.

Strategies are followed by pharmaceutical companies:-

• Personal Selling
• Symposium
• Sample Gifts
• Promotional Literature
• Conferences
• Direct Mailing

G.S.B.A, Greater Noida Page 12

 INDIAN PHARMACEUTICAL INDUSTRY -

G.S.B.A, Greater Noida Page 13

 Z &D
Against

Diarrhoea

PAEDIATRIC ZINC AS TREATMENT FOR DIARRHOEA

Every year approximately 1.7 million children die as a result of diarrhea and dehydration. In the majority
of cases, this is preventable through exclusive breastfeeding, improved hygiene and sanitation and access
to clean water, yet diarrhea is still one of the leading causes of death among children under five.

In May 2004, WHO/UNICEF issued a joint statement recommending the use of zinc, an essential
micronutrient for human growth, development and maintenance of the immune system, and a new
formulation oral rehydration solution (ORS), with reduced levels of glucose and salt, as a two-pronged
approach to improved case management of acute diarrhea in children.

Dispersible zinc tablets, which dissolve easily in a tablespoon of clean water or breast milk, can be used
for zinc supplementation for children aged one to 59 months

CONSEQUENCES OF ZINC DEFICIENCY-

1. Wilson disease.

2 acrodermatitis enteropathica.

3 Impaired cognitive function,

4 Behavioral problems,

5 Impaired memory,

6 Learning disability and neuronal atrophy

G.S.B.A, Greater Noida Page 14

DR. REDDY’S LAUNCHES Z&D’- ZINC THERAPY FOR
EFFECTIVE MANAGEMENT OF DIARRHOEA :-

Dr Reddy’s has launched “Z&D”- a Zinc Sulphate formulation indicated as Adjuvant therapy along with
ORS in the management of Acute and persistent Diarrhea. Available in 10 & 20 mg Dispersible orange
flavoured Tablets as well as in 10mg/ml & 20mg/ml Dry Syrup for pediatric use, this product is intended
to supplement the ORS (Oral Rehydration Salt) market.

Dr. Reddy’s is pioneer of low osmolarity ORS in India as per WHO /UNICEF guidelines. In diarrhea
management Dr Reddy’s has a complete basket of Brands Like Rebalanz, Redotil, Lactiflora and
Econorm. Dr Reddy’s launch of this Zinc Formulation will complement its existing product portfolio and
will also support a social initiative under its program - “Drive against Diarrhea”.

Z & D has been launched nationwide. The launch of the product will commence with a series of activities
across the country in form of CMEs (Continuing Medical Education), Patient Education Programs,
Awareness Camps and Social Mobilization Events like ORS Marathons.

STRENGTHS SWOT ANALYSIS OF Z&D-

(1) The time tested and trusted zinc therapy.

(2) Z&D is available in dispersible Tablets & Dry Syrup (10mg and 20mg pack).
(3) Each drop of 10mg pack and 20mg pack is having 10mg and 20mg zinc respectively.
(4) Available in delicious orange flavour.
(5) Each drop of Z&D strongly supports WHO & IAP statement.
(6) Ensures high therapeutic efficacy and clinical benefits.
(7) Highly helpful in the treatment of Acute diarrhea.
(8) Competencies in chemistry and process development.

WEAKNESS

(1) Comparatively costlier than the other brands.

(2) Not available in a wide range in the market.
(3) Characterized by low margins.
(4)

G.S.B.A, Greater Noida Page 15

OPPORTUNITIES

(1) Potential to replace other zinc therapy brands from the market.
(2) Can capture a great market in rural areas which are very prone to diarrhea infection simply by
reducing prices and better advertisement.
(3) Can extend its arms in other developing countries like Bangladesh, Turkish etc where
Diarrhoea infection is large.

THREATS

(1) Other low priced brand can capture great market share.
(2) Within India, Z&D’s largest rivals are—

ZINCONIA

ZINSY

ZEMIN

ANALYSIS
G.S.B.A, Greater Noida Page 16
The Summer Training completed in two phases -

1st Phase for 15days-

2nd Phase for 15days –

1ST PHASE:-
Objective: - To know the availability of DRL’s product in the specified areas so that on that information
management can maintain a smooth flow of products in the same.

Materials & Methods: - The following lists of products were given

PRODUCTS

DOXOBID (Doxophylline 400 mg)

Z&D (Zinc Sulphate 10 & 20 mg DT. & dry Syp.)
MUCOLITE –SR (Ambroxol 75 mg sustained release Cap)
Pecef (DT&Sus) (Cefpodoxime Proxitill 50/100 mg )

Following areas as per the dates given below –

G.S.B.A, Greater Noida Page 17

 PRODUCT
DATE AREA MEDICAL STORES AVAILABILITY

Doxo Z& Muc

Pecef
bid D olite

3/05 /09 Krishna Nagar BATRA MEDICOS √ √ √ √

SARASWATI MEDICOS √ √ √ √
BIMAL MEDICOS √ √ √ √
ARORA CHEMIST √ √ √ √
KAPOOR MEDICOS √ √ √ √
SAHIL MEDICOS √ √
BATRA MEDICINE
CORNER √ √ √ √
SHIVA MEDICOS √ √
HARSH MEDICOS √ √ √ √
SAPRA MEDICOS √ √ √ √
VIVEK MEDICOS √ √ √ √
SHIVA MEDICOS √ √ √ √
MEDICINE PALACE √ √
VEEKAY MEDICOS √ √ √
CHEMIST MEDICINE
PALACE √ √ √ √
RELIANCE MEDICARE √ √ √ √
SUPER MEDICOS √ √ √ √
CHEMIST PAWHA
PHARMACY √ √ √ √
DEEKAY MEDICOS √ √ √
STAR MEDICOS √ √ √ √
IRWIN MEDICOS √ √ √ √
FRIENDS MEDICOS √ √ √ √
SHIV SHYAM MEDICOS √ √
HARSH MEDICOS √ √ √ √
BHHASIN MEDICAL STORE √ √ √ √
SAHIL MEDICOS √ √ √ √
SHIV MEDICOS √ √ √
TRIVENI MEDIWAYS v √ v
KAPOOR MEDICOS √ √ √
BATRA MEDICOS √ √ √ √
SHIVA MEDICOS √ √ √
SARASWATI MEDICAL √
VIMAL MEDICOS √ √ √ √
SAPRA MEDICAL STORE √ √ √
SINGH MEDICOS √ √ √
BHAI MEDICOS √ √ √ √
KUSHYAP MEDICAL STORE √ √
POOJA MEDICOS √ √ √ √
PARIKH MEDICOS √ √ √
HANS MEDIWAYS √ √ √
SRIRAM MEDICOS √ √
MEDICOS CHEMIST √ √ √ √
G.S.B.A, Greater Noida GUPTA MEDICAL STORE √ √ Page 18
9/06/09 Shahadara SACHIN MEDICOS √ √ √ √
POOJA MEDICOS √ √ √ √
ARORA MEDICOS √ √ √ √
 Raj medicos √ √ √ √
Sharma medicos √ √ √
Jagdamba medicos √ √ √ √
Karshini medical store √ √ √
Kartik medicos √ √ √ √
Bhardwaj medical store √ √ √
Shri balaji medicos √ √ √ √
Sapna medical store √ √ √
Blason medicos √ √ √ √
Raj medical store
√ √ √
Kumar medical store
√ √ √ √
Surya medical store
√ √ √
Jai ambey medicos
√ √ √ √
Suneja medical store
√ √ √
Tarun medical store
√ √ √ √
Neraj medical store
√ √ √
Sachin medical store
√ √ √
Happy medical store
√ √ √ √
Mahi medical store
√ √ √
Gaurav medical store √ √ √
Suresh medical store
√ √ √ √
Sapna medical store
√ √ √
R.M medical store
√ √ √ √
Pee kay medical store
√ √ √ √
Kapoor medical store √ √ √
Keshav gupta
√ √ √
Plus point pharma √ √ √ √
Goyal medicos
√ √ √
Dass medical store
√ √ √
Ishan medical store
√ √ √ √
Shri ram medical store
√ √ √

G.S.B.A, Greater Noida Page 19

G.S.B.A, Greater Noida Page 20
 VIDYA MEDICOS √ √ √ √
JINDAL PHARMA √ √ √ √
SAI MEDICAL STORE √ √
BHATT MEDICAL STORE √ √ √ √
PRASAD MEDICOS √ √ √ √
DEEPAK MEDICOS √ √ √ √
AJAY CHEMIST √ √ √ √
BAHAL MEDICOS √ √
SHRI KRISHNA √ √ √ √
RAMA MEDICOS √ √ √
VASISTHA MEDICOS √ √ √ √
C R S HEALTH CARE √ √ √ √
JENENDRA MEDICOS √ √
SUPER MEDICOS √ √ √
PUJARI MEDICOS √ √ √
MED. CORNER √ √ √ √
DRUG POINT √ √ √ √
NAVEEN MEDICOS √ √ √ √
FAMILY MED. STORE √ √ √
RAJ MEDICOS √ √ √ √
BHATT MEDICOS √ √ √
JAI MEDICAL STORE √ √ √ √
JINDAL MEDICOS √ √ √
BHAGWATI MEDICOS √ √ √ √
PREM JI MEDICAL STORE √ √ √ √
VANDARI DISPENSARI √ √ √ √
SURYA MEDICAL √ √ √ √
SIMRAN MEDICOS √ √ √ √

G.S.B.A, Greater Noida Page 21

Total no. of Chemists covered in six days- 110

Results: - I observed the following things during my market survey: -

(1) From the List- Two

No. of chemists were having –

Pecef (DT&Sus) (Cefpodoxime Proxitill 50/100 mg) -63

DOXOBID (Doxophylline 400 mg) -62

Z&D (Zinc Sulphate 10 & 20 mg DT. & dry Syp.) - 69

MUCOLITE –SR (Ambroxol 75 mg SR Cap) - 54

(2) Z&D competitors

COMPETITORS OF Z&D-

BRAND
NAME MANUFACTURERS
ZINCONI
A ZUVENTUS
ZINCOVIT APEX LAB.LTD.
ZINSY PHARMED MEDICARE PVT.LTD
RICONIA RANBAXY

G.S.B.A, Greater Noida Page 22

2nd PHASE
This phase covered in a hospital –

(A) CHACHA NEHRU BAL CHIKITSALAYA,GEETA COLONY -- CNBC, DELHI

SWAMI DAYANAND HOSPITAL, SHAHADRA, DELHI—S.D.N.HOSPITAL-

Objective: - To collect the data regarding prescriptions for Diarrhoea with a main focus on Z&D and
its competitors.

G.S.B.A, Greater Noida Page 23

 Materials & Method: - In S.D.N.Hospital 90% cases were coming of Acute Diarrhoea (A.D)

I was in regular touch with the paediatrics doctors recommending. Zinc Therapy in the form of Syp.
Zinconia and other brands.

After telling Z&D and its features to them, I found drastic change in prescriptions.Most of doctors was
prescribing Z&D.

Ragarding data collection, were given information sheets from DRL’S side. I collected data from 8
doctors-

• DR. M.L. JAIPAL (HEAD OF PAEDIARTRICS, S.D.N.)

• DR. S.B. SINGH
• DR.S.S. BISHT
• DR. JASWANT SINGH
• DR. ANIL KUMAR SAINI

SHEET OF THE COLLECTED DATA-

NAME OF THE DOCTOR- DR. JASWANT SINGH HOSPITAL-SDH

ZINC
S.NO. PATIENT NAME A.D/P.D ORS THERPY ANTIBIOTIC ANY OTHER MEDICATION
1 Rohit A.D ORS ------ Norfazole Syp Vomitend
Syp Clavimax,Mentnal
2 Ramesh A.D ORS ------- TZ Syp PCM
3 vinita A.D ORS ZINCONIA Norfazole Syp PCM,Tab. Cafrixime
4 Nidhi A.D ORS Z&D ----- Syp PCM
5 Komal A.D ORS --------- --------- Cyclopam
6 Mohan A.D ORS Z&D ---------- -----------
7 Tena A.D ORS -------- Norfazole Zomatril
8 Salman A.D ORS Ofloxmn -----------

G.S.B.A, Greater Noida Page 24

9 Kusum A.D ORS Z&D Syp Mentnal TZ Zomatril
10 Amit A.D ORS Z&D ----------- Syp PCM
11 Sunil A.D ORS Z&D Syp Mentnal TZ Zomatril
12 Sumitl A.D ORS Syp Mentnal TZ Cyclopam
13 Sameer A.D ORS Z&D Syp Mentnal TZ Syp PCM,Cetrizine
14 Varun A.D ORS Z&D Norfazole Syp PCM
15 Lalita A.D ORS ZINCONIA Norfazole,Clavimax Syp PCM,Tixylix
16 Akshat A.D ORS ZINCONIA Syp. Norfazole Syp PCM
Syp Clavimax,Mentnal
17 Fazal A.D ORS --------- TZ Syp PCM,Syp Bronchrax
20 Mohd. Asif A.D ZINCONIA Cap. Penclax Syp PCM,Syp Bronchrax
21 Ashu A.D ORS Z&D -------- Phenairgen
22 Urmi A.D ORS -------- ---------
23 Twinkle P.D ORS Z&D -------- Nutralin B
24 Muskan A.D ORS Z&D Mentnal TZ Inj. Perinom,Phenairgen,
25 Nishika A.D ORS Syp. Norfazole Syp. PCM, Tab. Cafrixime
Syp. Perinom, Racigyl
26 Sahil khan A.D ORS Z&D ---------- sachet(mg)
K.V.O., Inj. Ampi.250 mg,Inj.
27 Charu A.D ORS ZINCONIA Syp. Norfazole Perinom
28 Farookh A.D ORS Z&D Mentnal TZ Syp. PCM
29 Rohit A.D ORS Z&D Mentnal TZ Zomatril
30 Sadaam A.D ORS Z&D Syp.Mentnal TZ Inj. Perinom

G.S.B.A, Greater Noida Page 25

 MARKET SHARE IN SDN HOSPITAL

Z&D
25%
ZEMIN
38%

in

ZINSY
42%

Z&D ZINSY ZEMIN

Total No. of prescription seen- 380

Total No. of prescriptions for Z&D (before doctor visits) - 155

Total No. of prescriptions for Z&D (after doctor visits) – 219

Total No. of prescription for other zinc therapies (before doctor visits) – 220

Total No. of prescription for other zinc therapies (after doctor visits) - 160

Results: -

Most of the doctors preferred Z&D as Zinc Therapy against diarrhea. Chacha Nehru Bal
Chikitsalaya,Delhi

G.S.B.A, Greater Noida Page 26

 INFLUENCE OF VARIOUS FACTORS PRESCRIBING
Z&D-
1:- Dosage form.

2:- Advertisement.

3:-Frequency of doctor visits by Medical representitative.

4:- Samples & gifts.

5:- Quality of products.

6:- Aviability of products.

QUESTIONNAIRE FOR CHEMISTS

G.S.B.A, Greater Noida Page 27

Q. Please mark on those medicines of Dr. Reddy’s which are available in your store—
Here is the product list---

Q. What are the brands you most frequently sell of (products) ?

BRAND NAME PACK NO. OF UNITS

Q. How much stock do you have from the latest introduction of DR.REDDY’S LAB.LTD?

Latest Introduction of Dr.Reddy’s are:-

PRODUCTS NO. OF UNITS

DOXOBID (Doxophylline 400 mg)

MUCOLITE –SR (Ambroxol 75 mg sustained release Cap)
Pecef (DT&Sus) (Cefpodoxime Proxitill 50/100 mg )

Q. Doctors preferring the DRL brand are-

NAME OF THE DOCTOR HOSPITAL

Q. Doctors preferring the other brands of eg Doxobid against respirstory disease are-

BRAND NAME NAME OF THE DOCTOR HOSPITAL

Q. Any complaints from the patients?

A. ------------------------------------------------------------------

SUGGESTIONS & RECOMMENDATIONS TO BOOST

UP SALES OF DRL-
G.S.B.A, Greater Noida Page 28
Following things may be helpful in increasing the sales of a company, these are:-

 Frequent Doctors Visits.

 Availability of products with retailers.
 Reputation of company.
 Cost of product.
 Relations with Doctors.
 Samples & Gifts.
 Dosage.
 Advertisement in medical journals.
 Quality assurance.
 Maintaning better relations with the doctors.

DRL is taking very most care to satisfy the above factor however but a little extra care & also monitors
the feedback provided by its marketing executives then the results will boost up.

In my view following key factors should also be kept in mind.

 Before launching a new product company should provide information to the chemists by
arranging get together & Seminars.
 Company should keep in mind about cost factor
 Quality of the products should be maintained.
 Company should give more profit to the chemists
 The company should work more on replacement schemes.
replacement of expired medicines.

BIBLIOGRAPHY

G.S.B.A, Greater Noida Page 29

(A) NEWS PAPERS:-

 ECONOMIC TIMES
 TIMES OF INDIA
 BUSINESS TODAY

(B) MAGZINES:-

 BUSINESS INDIA
 BUSINESS WORLD
 INDIA TODAY

(C) BOOKS:-

 MARKETING MANGEMENT - PHILIP KOTLER

 GSBA LIBRARY.

G.S.B.A, Greater Noida Page 30